Table 2.
Preferences within each topic area and corresponding prioritization results
| Preferences Discussed within Each Topic Area | Vote Count | Priority Ranka |
|---|---|---|
| Recruitment and consent process | ||
| Technology use for recruitment by health care team | 11 | High |
| Consent provided by family member | 8 | High |
| Multiple methods for consent (e.g., one-on-one discussion, visual materials [posters, videos, etc.]) | 7 | Medium |
| Informed consent with knowledgeable and trusted person | 6 | Medium |
| Technology use for recruitment by research team | 4 | Low |
| Informed consent provided by responsible physician | 4 | Low |
| Intervention delivery | ||
| Acceptability of a new IV cannula if needed | 10 | High |
| Support and reimbursement for return visits to receive intervention | 9 | High |
| Intervention duration of more than 1 wk | 7 | Medium |
| Intervention administration only during hospital admission | 5 | Medium |
| Acceptability of return visits after discharge to receive additional intervention doses if needed | 5 | Medium |
| Intervention duration of 1 wk or less | 1 | Low |
| Trial outcomes | ||
| Short-term and long-term measures of kidney function (e.g., serum creatinine, need for dialysis, AKI severity) | 10 | High |
| Other patient health complications (e.g., cardiovascular events, death) | 8 | High |
| Health care utilization (e.g., hospital readmission, emergency department visits, length of stay, nephrology follow-up) | 5 | Medium |
| Mental health outcomes (e.g., anxiety, depression) | 5 | Medium |
| Drug-related adverse events | 4 | Low |
| Activities of daily living, independence, and functional status (e.g., return to work) | 4 | Low |
| Physical health, symptoms, and patient-reported outcomes | 2 | Low |
| Caregiver outcomes (e.g., caregiving burden, mental health) | 2 | Low |
IV, intravenous.
a
Priority assignment based on number of votes (i.e., dots), defined as high (≥7 dots), medium (3–6 dots), and low (<3 dots) priority.